[Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP's activities]
- PMID: 22874489
- DOI: 10.2515/therapie/2012017
[Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP's activities]
Abstract
Background: Spontaneous reporting of adverse drug reactions (ADR) is fundamental to drug safety surveillance (pharmacovigilance) and assessment of benefit/risk ratio. However, under-reporting remains the limit of the system.
Objective: The aim of this study was to assess the effect of regular visits of an Assistant in Clinical Research (CRA) on the improvement of ADR reporting in non-university hospitals.
Methods: We set up an ADR report collecting system that involved regular visits in non-university hospitals, We began the visits in 2006 in 2 areas (Haute Garonne and Gers), extended to 4 other areas in 2009. We compared the reporting rate (number of reports/number of beds) of total ADRs reported by non-university hospitals in these areas before (one year) and after the start of CRA visits.
Results: A total 2831 of reports were collected by the CRA: 40% were "serious" including two deaths. The results suggest an increase of 100% of the rate of reporting of ADRs.
Conclusion: This study shows that regular visits increases the number of ADRs reported by non-university hospitals. Further assessment of this procedure is necessary for long term evaluation of its effectiveness.
© 2012 Société Française de Pharmacologie et de Thérapeutique.
Similar articles
-
Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.Drug Saf. 2010 May 1;33(5):409-16. doi: 10.2165/11319170-000000000-00000. Drug Saf. 2010. PMID: 20397740
-
[Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits].Therapie. 2017 Jun;72(3):351-355. doi: 10.1016/j.therap.2016.09.004. Epub 2016 Oct 27. Therapie. 2017. PMID: 27865436 French.
-
A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.Int J Pharm Pract. 2014 Aug;22(4):275-82. doi: 10.1111/ijpp.12078. Epub 2013 Nov 5. Int J Pharm Pract. 2014. PMID: 24188533
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Limitations and strengths of spontaneous reports data.Clin Ther. 1998;20 Suppl C:C40-4. doi: 10.1016/s0149-2918(98)80007-6. Clin Ther. 1998. PMID: 9915089 Review.
Cited by
-
Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting.Drug Saf. 2018 May;41(5):511-514. doi: 10.1007/s40264-017-0630-2. Drug Saf. 2018. PMID: 29270770
-
Promoting adverse drug reaction reporting: comparison of different approaches.Rev Saude Publica. 2016;50:14. doi: 10.1590/S1518-8787.2016050006122. Epub 2016 May 3. Rev Saude Publica. 2016. PMID: 27143614 Free PMC article.
-
Improving adverse drug event reporting by healthcare professionals.Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD012594. doi: 10.1002/14651858.CD012594.pub2. Cochrane Database Syst Rev. 2024. PMID: 39470185 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
